About Index Trending news
Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals, Inc.

Work at Concert Pharmaceuticals, Inc.? Add yourself to this profile

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals is a biotechnology company utilizing deuterium todevelop novel medical candidates.


Contributors to this profile

Alexa global traffic share

12 Jun 2017
Post-IPO debt
Hercules Capital, Inc.

Concert Pharmaceuticals Announces $30 Million Venture Debt Financing from Hercules Capital

30 Apr 2008
Venture capital (Series C)
Adage Capital Management, Flagship Ventures, Greylock Partners, +9
Added by
30 Nov 2006
Venture capital (Series B)
Added by

Concert Pharma Raises $48.5 Million

PE Hub
17 Jul 2006
Venture capital (Series A)
Greylock Partners, Skyline Ventures, QVT Financial, +2
Added by